Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Barlesi

Showing results (21-30 of 343) with videos related to

Pageof 35
Sort By:
Clinical Lung Cancer|February 8, 2005
Biologic staging of non-small-cell lung cancer: prospect or proposal?Fabrice Barlesi, William Jacot, Jean-Louis Pujol
Cancer Treatment Reviews|May 25, 2023
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)Claudia Parisi, Linda Mahjoubi, Anas Gazzah, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 17, 2017
Personalised medicine for nonsmall cell lung cancerCéline Mascaux, Pascale Tomasini, Laurent Greillier, et al.
Bulletin Du Cancer|September 26, 2020
[Predictable toxicities with futures immunotherapies or combinations]Alice Mogenet, Pascale Tomasini, Laurent Greillier, et al.
Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2006
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trialsJean-Louis Pujol, Fabrice Barlesi, Jean-Pierre Daurès
Therapeutic Advances in Medical Oncology|March 17, 2012
Ipilimumab: its potential in non-small cell lung cancerPascale Tomasini, Nataliya Khobta, Laurent Greillier, et al.
Current Oncology Reports|August 18, 2020
Immune Oncology Biomarkers in Lung Cancer: an OverviewCamille Travert, Fabrice Barlesi, Laurent Greillier, et al.
Oncotarget|August 31, 2018
Immunologically effective dose: a practical model for immuno-radiotherapyRaphaël Serre, Fabrice Barlesi, Xavier Muracciole, et al.
Bulletin Du Cancer|January 30, 2023
[Use of genome-wide testing in oncology: French expert opinion based on the Delphi methodology]Olivier Trédan, Caroline Robert, Antoine Italiano, et al.
Pageof 35

Showing results (21-30 of 343) with videos related to

Sort By:
Pageof 35
Clinical Lung Cancer|February 8, 2005
Biologic staging of non-small-cell lung cancer: prospect or proposal?Fabrice Barlesi, William Jacot, Jean-Louis Pujol
Cancer Treatment Reviews|May 25, 2023
TROP-2 directed antibody-drug conjugates (ADCs): The revolution of smart drug delivery in advanced non-small cell lung cancer (NSCLC)Claudia Parisi, Linda Mahjoubi, Anas Gazzah, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|November 17, 2017
Personalised medicine for nonsmall cell lung cancerCéline Mascaux, Pascale Tomasini, Laurent Greillier, et al.
Bulletin Du Cancer|September 26, 2020
[Predictable toxicities with futures immunotherapies or combinations]Alice Mogenet, Pascale Tomasini, Laurent Greillier, et al.
Therapeutic Advances in Medical Oncology|May 31, 2016
Pemetrexed for advanced stage nonsquamous non-small cell lung cancer: latest evidence about its extended use and outcomesPascale Tomasini, Fabrice Barlesi, Celine Mascaux, et al.
Lung Cancer (Amsterdam, Netherlands)|February 16, 2006
Should chemotherapy combinations for advanced non-small cell lung cancer be platinum-based? A meta-analysis of phase III randomized trialsJean-Louis Pujol, Fabrice Barlesi, Jean-Pierre Daurès
Therapeutic Advances in Medical Oncology|March 17, 2012
Ipilimumab: its potential in non-small cell lung cancerPascale Tomasini, Nataliya Khobta, Laurent Greillier, et al.
Current Oncology Reports|August 18, 2020
Immune Oncology Biomarkers in Lung Cancer: an OverviewCamille Travert, Fabrice Barlesi, Laurent Greillier, et al.
Oncotarget|August 31, 2018
Immunologically effective dose: a practical model for immuno-radiotherapyRaphaël Serre, Fabrice Barlesi, Xavier Muracciole, et al.
Bulletin Du Cancer|January 30, 2023
[Use of genome-wide testing in oncology: French expert opinion based on the Delphi methodology]Olivier Trédan, Caroline Robert, Antoine Italiano, et al.
Pageof 35